GeoPolitics Pulse

The Heartbeat of World events

Ipsen’s Iqirvo® (elafibranor) approved in the European Union as first new treatment for …

by ·

… European Union as first new treatment for primary biliary cholangitis in nearly a decade. Rare Diseases – 20 September 2024 – 8 mins read. European …Read More

Related posts:

  1. Vitamin B12 treatment Rozebalamin approved for ALS in Japan – ALS News Today
  2. TEPOXX (tecovirimat) Approved in Japan for the Treatment of Orthopoxviruses – BioSpace
  3. Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy …
  4. Mirum Pharmaceuticals’ LIVMARLI Approved in the European Union for Patients with PFIC
  5. Dupixent® (dupilumab) Approved in the European Union as the – GlobeNewswire